Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 22, 2020
Clinicopathological characteristics of glomeruloid architecture in prostate cancer
Eva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Neoplasia (New York, N.Y.)
|
June 17, 2011
Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer
Geertje van der Horst, Christel van den Hoogen, Jeroen T Buijs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 21, 2020
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
Eva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 27, 2021
Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients
Tim Hansum, Eva Hollemans, Esther I Verhoef, et al.
Cancer Research
|
June 3, 2010
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer
Christel van den Hoogen, Geertje van der Horst, Henry Cheung, et al.
BJU International
|
November 17, 2009
Pelvic floor dysfunction is not a risk factor for febrile urinary tract infection in adults
Cees van Nieuwkoop, Petra J Voorham-van der Zalm, Anne-Marike van Laar, et al.
Molecular Therapy. Oncology
|
February 3, 2026
Improved oncolytic and immunostimulatory activity of the spontaneous <i>jin-3</i> reovirus mutant in preclinical bladder cancer models
Arjanneke F van de Merbel, Maaike H van der Mark, Lobke C M Hensen, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
November 4, 2024
A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder Cancer
Joep J de Jong, Florus C de Jong, Angelique C J van der Made, et al.
JACC. Cardiooncology
|
November 29, 2022
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
Fleur H J Kaptein, Tom van der Hulle, Sander J E Braken, et al.
Molecular Oncology
|
September 8, 2020
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
Geertje van der Horst, Arjanneke F van de Merbel, Eline Ruigrok, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 22, 2020
Clinicopathological characteristics of glomeruloid architecture in prostate cancer
Eva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Neoplasia (New York, N.Y.)
|
June 17, 2011
Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer
Geertje van der Horst, Christel van den Hoogen, Jeroen T Buijs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 21, 2020
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
Eva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 27, 2021
Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients
Tim Hansum, Eva Hollemans, Esther I Verhoef, et al.
Cancer Research
|
June 3, 2010
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer
Christel van den Hoogen, Geertje van der Horst, Henry Cheung, et al.
BJU International
|
November 17, 2009
Pelvic floor dysfunction is not a risk factor for febrile urinary tract infection in adults
Cees van Nieuwkoop, Petra J Voorham-van der Zalm, Anne-Marike van Laar, et al.
Molecular Therapy. Oncology
|
February 3, 2026
Improved oncolytic and immunostimulatory activity of the spontaneous <i>jin-3</i> reovirus mutant in preclinical bladder cancer models
Arjanneke F van de Merbel, Maaike H van der Mark, Lobke C M Hensen, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
November 4, 2024
A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder Cancer
Joep J de Jong, Florus C de Jong, Angelique C J van der Made, et al.
JACC. Cardiooncology
|
November 29, 2022
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
Fleur H J Kaptein, Tom van der Hulle, Sander J E Braken, et al.
Molecular Oncology
|
September 8, 2020
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
Geertje van der Horst, Arjanneke F van de Merbel, Eline Ruigrok, et al.
Page
of 10